Skip to content
AnalystLens

METLIFE INC 8-K Report, Regulation FD Disclosure (Apr 7, 2026)

Reports
Regulation FD
Filing Date
Filed April 7, 2026
Period End
April 7, 2026
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’23Mar ’23
  3. Leadership change8-K · Mar ’25Mar ’25

Summary

Summary of the 8-K filed April 7, 2026. Cited figures are marked; the original filing is the authoritative source.

MetLife, Inc. (MET) has filed a Form 8-K to provide preliminary guidance on its variable investment income for the first quarter of 2026.

The company estimates this income, which includes returns from private equity, real estate, and other funds, as well as prepayment fees, to be between $475 milliona and $525 million on a pre-tax basis. This figure is part of the company's previously issued full-year 2026 guidance of approximately $1.6 billion in variable investment income. While this provides early insight into a key component of MetLife's investment performance, investors are cautioned that these numbers are preliminary, unaudited, and based on information available as of the filing date.

Actual results could differ materially once full financial closing procedures are completed. The company emphasizes that this disclosure should not be seen as a substitute for their full U.S. GAAP financial statements and that no inferences should be drawn about other financial or operating data not provided here.

Key Highlights

  1. MetLife is providing preliminary, pre-tax variable investment income guidance for Q1 2026, estimated between $475 million and $525 million.
  2. This Q1 estimate aligns with the company's full-year 2026 guidance for variable investment income, which is approximately $1.6 billion (pre-tax).
  3. Variable investment income comprises earnings from private equity, real estate, other funds, and prepayment fees.
  4. The disclosed figures are preliminary, unaudited, and subject to change upon completion of financial closing procedures.
  5. Investors are strongly advised to exercise caution and not rely solely on this preliminary data.
  6. The disclosure does not provide other financial or operating data for the quarter.
  7. This information is furnished under Regulation FD and is not considered 'filed' for Section 18 purposes.

Frequently Asked Questions

  1. What is 'variable investment income' and why is MetLife disclosing it separately?

    Variable investment income at MetLife includes earnings from investments in private equity, real estate funds, other alternative investment funds, and prepayment fees received on their investments. The company provides this breakdown as it represents a segment of their investment portfolio that can be more volatile than traditional fixed-income assets, and giving preliminary figures can help investors better track its performance throughout the quarter.

  2. How does the estimated Q1 2026 variable investment income compare to the full-year guidance?

    The preliminary estimate of $475 million to $525 million for Q1 2026 represents a significant portion of the company's full-year 2026 guidance, which is set at approximately $1.6 billion. If the upper end of the Q1 range ($525 million) is achieved, it would suggest that roughly 33% of the full-year target could be met in the first quarter alone.

  3. What are the risks associated with this preliminary information?

    The primary risk is that the preliminary numbers are unaudited and based on incomplete financial closing procedures. Actual results could differ materially from the estimates provided. MetLife explicitly states that prospective investors should exercise caution and not rely solely on this information, as it is not a substitute for their audited financial statements and may not be indicative of future periods.

  4. When will MetLife release its full, audited financial results for the first quarter of 2026?

    MetLife, Inc. has scheduled its quarterly earnings release and quarterly financial supplement for the quarter ended March 31, 2026, for May 6, 2026. This date will mark the release of their complete and audited financial results.